Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameJoyzyme Group
Stock Code08622
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities本集團專注於在中國研發、生產及銷售男性不育、寄生蟲系列及EB病毒等體外診斷試劑,並銷售輔助生育用品和設備。
Listing Date2018-12-13
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國深圳市大鵬新區葵涌街道葵新社區銀葵路16號深圳君軒D棟一至三層
Business Address (Hong Kong)香港中環德輔道中100號2樓
Place of Incorporation開曼群島
Listing Method發售以供認購 + 發售以供配售
Listing BoardGEM
Websitewww.szhuakang.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 0.50 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer Period2018-11-30 to 2018-12-05
Global Offering Shares100,000,000 shares
HK Public Offer Shares (Initial)10,000,000 shares (10.0%)
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)90,000,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO400,000,000 shares
Greenshoe (Over-allotment Option)No
Stabilizing Manager (Greenshoe)—
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 50,000,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
HK Market Cap HK$ 139.4M
Est. Threshold HK$ 9.39B
Analysis Result HK market cap below threshold, need +6637%

Valuation & Financials

Market Cap (at Offer Price)HK$ 200,000,000
Pre-IPO Valuation (Last Round)Not disclosed
P/E Ratio不適用(公司處於虧損狀態)
Profit/Loss Status虧損人民幣1.95百萬元
Period-End Cash BalanceTo be extracted
Listing Expenses~HK$ 33,800,000
Listing Expenses / Funds Raised~67.6%
Total Pre-IPO Investment港元20.0百萬元

Financial Data

Unit: '000 RMB
Income Statement
Item 2015201620172018-05
Revenue 19,45625,41026,54111,012
Cost of sales -5,088-7,788-8,007-2,841
Gross profit 14,36817,62218,5348,171
Other income and gains, net 2,062-1,140860135
Selling and distribution expenses -2,734-2,910-2,860-1,297
Administrative expenses -1,565-2,290-3,244-1,776
Operating profit 10,48710,072-1932,198
Net finance costs -1,284-128-540
Profit before tax 9,2039,944-2472,198
Income tax expense -1,269-1,518-1,705-728
Profit for the year 7,9348,426-1,9521,470
Profit attributable to owners 7,9348,426-1,9521,470
Balance Sheet
Item 2015201620172018-05
Cash and cash equivalents 6,09315,91419,81117,814
Trade and bills receivables 7,3689,4149,84811,388
Inventories 2,3812,4081,9451,851
Total current assets 19,62129,78235,91536,162
Total assets 27,48837,44848,42249,745
Total current liabilities 10,46312,63210,81210,684
Total liabilities 11,71313,24711,03210,885
Total equity 15,77524,20137,39038,860
Equity attributable to owners 15,77524,20137,39038,860
Interest-bearing borrowings 1,55095000
Cash Flow Statement
Item 2015201620172018-05
Net cash from operating activities 5,45511,2552,69957
Net cash from investing activities 6,246-1,569-4,380-1,735
Net cash from financing activities -9,1311355,578-319
Net increase in cash 2,5709,8213,897-1,997
Depreciation of PP&E 4786061,071532
Amortisation of intangible assets 33302351146
Purchase of PP&E -2,613-2,057-4,154-15
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 0.47
First Day OpenHK$ 0.495
First Day Change-6.00%
First Day Volume125728000.0
First Day Turnover64066800.0
Use of Proceeds
1、所得款項凈額41.5%(或6.9百萬港元)將用于開發新產品、改良我們的現有產品及開展國際合作項目; 2、所得款項凈額27.3%(或4.5百萬港元)將用于擴展我們的銷售網絡以及加強我們的銷售及營銷活動; 3、所得款項凈額27.9%(或4.6百萬港元)將用于發展輔助生育用品業務; 4、所得款項凈額3.3%(或548,000港元)將用于為營運資金撥付資金。

Underwriting Syndicate

Sole Sponsor (1)
RHB Capital Hong Kong Limited CE AGC194
Joint Bookrunners (2)
Funde Securities Limited CE BHT984 EVER-LONG SECURITIES COMPANY LIMITED CE ACM423
Joint Lead Managers (3)
Funde Securities Limited CE BHT984 Lego Securities Limited CE BIE918 Canfield Securities Company Limited CE BIH478

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman張曙光—
Company Secretary周麗麒—
No director data available.

Major Shareholders

Major Shareholders & Holdings張曙光先生(透過Crystal Grant)持有36.14%權益,張賢陽先生(透過Ever Charming)持有23.86%權益,合共60%,被視為一組控股股東。
About this page

This page shows Joyzyme Group (08622) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect